On October 28, Hca Healthcare Inc rose 3.1% in Regular Trading, trading around $464.0 per share, with turnover of $177 million.
The move followed stronger-than-expected third-quarter results and subsequent analyst target-price increases. The company reported revenue of $19.85 billion, up 3.6% year over year, and adjusted EPS of $7.22, above market expectations of about $6.65 to $6.66. Management also said full-year results are expected in the upper half of its prior guidance range.
Following the earnings release, analysts lifted their forecasts, including a target-price increase by Bernstein to $471. Recent consensus data cited a mean target price of about $473.33, reinforcing the positive reaction in the shares.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments